Contact

Phone: 440.312.8420
Fax: 440.312.8224
Email: mayzelb2@ccf.org

Education

  • Ambulatory Care Specialty Residency 2020, Beaumont Royal Oak, Royal Oak, MI.
  • Resident Teaching and Learning Curriculum 2019, Wayne State University College of Pharmacy, Detroit, MI.
  • Pharmacy Practice Residency, 2019, Cleveland Clinic Hillcrest Hospital, Mayfield Heights, OH.
  • Doctor of Pharmacy 2018, University of Toledo College of Pharmacy, Toledo, OH.

Areas of Interest

  • Diabetes.
  • Asthma and COPD.
  • Anticoagulation.
  • Chronic heart failure.

Current Projects & Committees

  • Ambulatory Care Services with Family Medicine and Internal Medicine.
  • Member of the Cleveland Clinic Research Enterprise Committee.
  • Member of Hillcrest Hospital Pharmacy and Therapeutic Committee.
  • Member of the American Society of Health-System Pharmacists.
  • Member of American College of Clinical Pharmacy.
  • American College of Clinical Pharmacy Ambulatory Care PRN.
  • Networking Committee Member.

Publications

  • Axtell, S, Nixon B. Implementing Transitions of Care Services in a Primary Care Clinic: Role of the Pharmacist. J Pharm Pract. 2023; 1- 6. https://doi.org/10.1177/08971900231165833
  • Chonko K, Axtell S, Mayzel B. Pharmacist Hypertension Management Quality Review at an Ambulatory Care Clinic. J Pharm Technol. 2022 Feb;38(1):31-38. doi: 10.1177/87551225211064240. Epub  2021
  • Mayzel B, Muench S, Lauster C. Impact of Pharmacist Education on Inhaler Technique and Adherence in an Outpatient Clinic. Hospital Pharmacy 2022;57(3):402-407.
  • Mayzel B, Axtell S, Richardson C, Link N. Impact of Pharmacist Face-to-Face Pharmacist Transitional Care Management Visits on Medication Related Problems. Journal of Pharmacy Technology February 2020; doi:10.1177/8755122520905582.
  • Mayzel B, Axtell S. Spironolactone’s role in resistant hypertension OCCP Newsletter 2019; 10:9.
  • Mayzel B, Axtell S. Cannabidiol for Lennox-Gastaut and Dravet Syndrome: A new treatment option. OCCP Newsletter 2018; 9:9.

Poster Presentations

  • Tasseff N, Nixon B, Axtell S. Impact of Glucagon-like Peptide 1 Agonist Therapy on Weight Loss in Type 2 Diabetes Patients. ACCP Global Conference, San Francisco, CA. October 2022
  • Mayzel B, Muench S, Lauster C. Impact of Pharmacist Education on Inhaler Technique and Adherence in an Outpatient Clinic. ASHP MCM National Conference, Las Vegas, NV. December 2019
  • Mayzel B, Axtell S, Richardson C, Link N. Impact of Pharmacist Face-to-Face Pharmacist Transitional Care Management Visits of Medication Related Problems. Ohio Pharmacy Resident Conference. Ada, OH. May 2019
  • Mayzel B, Axtell S, Richardson C, Link N. Impact of Pharmacist Face-to-Face Pharmacist Transitional Care Management Visits of Medication Related Problems. OCCP Fall 2018 Meeting. Rootstown, OH. October 2018
  • Mayzel B, Axtell S, Richardson C. Renal dosing appropriateness and adverse drug reaction incidence of empagliflozin and canagliflozin. Poster presentation. ASHP MCM National Conference, Anaheim, CA. December 2018
  • Mayzel B, Axtell S, Richardson C. Renal dosing appropriateness and adverse drug reaction incidence of empagliflozin and canagliflozin. Poster presentation. Vizient National Conference, Anaheim, CA. December 2018
  • Mayzel B, Axtell S, Richardson C. Renal dosing appropriateness and adverse drug reaction incidence of empagliflozin and canagliflozin. Poster presentation. ACCP Global Conference, Seattle, WA. October 2018